U.S. External Ventricular Drain Market Size, Share & Trends Analysis Report By Application (Traumatic Brain Injury, Subarachnoid Hemorrhage), By Patient Type (Pediatric, Adult), By End-use, By Country (South, West, Midwest), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within Immediate
U.S. External Ventricular Drain Market Growth & Trends
The U.S. external ventricular drain market size is anticipated to reach USD 1.2 billion by 2030, exhibiting a CAGR of 8.10% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by various factors such as novel product launches, rising healthcare expenditure, and increasing regulatory approval for EVD devices in traumatic brain injury treatment.
In this market, various stakeholders, including manufacturers, healthcare providers, and regulatory bodies, collaborate to ensure that effective and safe EVD solutions are readily available for patients recovering from different types of hemorrhage. For instance, in July 2023, Integra LifeSciences shared positive updates about the successful application of the Codman Bactiseal EVD catheter set in managing hydrocephalus, a complication often seen in patients who have experienced aneurysmal Subarachnoid Hemorrhage (aSAH). The outcomes emphasized favorable clinical & economic results associated with the use of this medical solution. This collective effort aims to enhance the overall quality of care and outcomes for individuals affected by this serious medical condition.
By placing an EVD, healthcare providers can consistently monitor the pressure inside the skull and make necessary adjustments to fluid drainage. This ongoing monitoring is essential for evaluating the patient's neurological condition and ensuring timely interventions.
U.S. External Ventricular Drain Market Report Highlights
U.S. External Ventricular Drain Market Growth & Trends
The U.S. external ventricular drain market size is anticipated to reach USD 1.2 billion by 2030, exhibiting a CAGR of 8.10% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by various factors such as novel product launches, rising healthcare expenditure, and increasing regulatory approval for EVD devices in traumatic brain injury treatment.
In this market, various stakeholders, including manufacturers, healthcare providers, and regulatory bodies, collaborate to ensure that effective and safe EVD solutions are readily available for patients recovering from different types of hemorrhage. For instance, in July 2023, Integra LifeSciences shared positive updates about the successful application of the Codman Bactiseal EVD catheter set in managing hydrocephalus, a complication often seen in patients who have experienced aneurysmal Subarachnoid Hemorrhage (aSAH). The outcomes emphasized favorable clinical & economic results associated with the use of this medical solution. This collective effort aims to enhance the overall quality of care and outcomes for individuals affected by this serious medical condition.
By placing an EVD, healthcare providers can consistently monitor the pressure inside the skull and make necessary adjustments to fluid drainage. This ongoing monitoring is essential for evaluating the patient's neurological condition and ensuring timely interventions.
U.S. External Ventricular Drain Market Report Highlights
- Based on product, the traumatic brain Injury segment is expected to register the fastest CAGR of 9.50% during the forecast period. TBI can lead to intraventricular bleeding (hemorrhage), requiring the use of EVD devices to remove excess cerebrospinal fluid from the brain. This directly increases the demand for EVD devices, thereby fostering market growth.
- Based on patient type, the pediatric segment is anticipated to grow at the fastest CAGR of 9.56% during the forecast period owing to the advancements in pediatric neuroimaging technologies, including CT scans & MRIs, which are improving the accuracy and timeliness of diagnosing TBIs in children.
- Based on end-use, the hospital segment is expected to register the fastest CAGR of 8.32% during the forecast period.Hospitals play a crucial role in diagnosing & managing neurological disorders such as TBI, Intracranial Pressure (ICP), and hydrocephalus. Serving as pivotal centers for patient care, these facilities often possess state-of-the-art medical technology and employ a team of skilled healthcare specialists.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EXTERNAL VENTRICULAR DRAIN MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of neurological disorders
3.2.1.2. Increasing healthcare expenditure
3.2.1.3. Developments of novel EVD technologies
3.2.2. Market Restraint Analysis
3.2.2.1. Infections and complications caused due to EVD insertion
3.2.3. Market Opportunities Analysis
3.2.3.1. Growing awareness regarding neurological illnesses
3.2.3.2. Increasing demand for minimally invasive procedures
3.3. U.S. External Ventricular Drain Market Analysis Tools
3.3.4. Industry Analysis - Porter’s Five Forces
3.3.4.1. Bargaining power of suppliers
3.3.4.2. Bargaining power of buyers
3.3.4.3. Threat of substitutes
3.3.4.4. Threat of new entrants
3.3.4.5. Competitive rivalry
3.3.5. PESTEL Analysis
3.3.5.1. Political & Legal Landscape
3.3.5.2. Economic and Social Landscape
3.3.5.3. Technological landscape
CHAPTER 4. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. External Ventricular Drain Market Movement Analysis
4.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Traumatic Brain Injury
4.4.1. Traumatic Brain Injury Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Subarachnoid Hemorrhage
4.5.1. Subarachnoid Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Intracerebral Hemorrhage
4.6.1. Intracerebral Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Other Non-traumatic Hydrocephalus Conditions
4.7.1. Other Non-traumatic Hydrocephalus Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: PATIENT TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. External Ventricular Drain Market Movement Analysis
5.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
5.4. Adult
5.4.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Pediatric
5.5.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. External Ventricular Drain Market Movement Analysis
6.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: COUNTRY ESTIMATES & TREND ANALYSIS BY APPLICATION, BY PATIENT TYPE, BY END-USE
7.1. Regional Dashboard
7.2. Market Size and Trend Analysis, 2018 to 2030
7.3. South
7.3.1. Key country dynamics
7.3.2. Competitive scenario
7.3.3. Regulatory framework
7.3.4. Reimbursement scenario
7.3.5. South Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. West
7.4.1. Key country dynamics
7.4.2. Competitive scenario
7.4.3. Regulatory framework
7.4.4. Reimbursement scenario
7.4.5. West Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Midwest
7.5.1. Key country dynamics
7.5.2. Competitive scenario
7.5.3. Regulatory framework
7.5.4. Reimbursement scenario
7.5.5. Midwest Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Northeast
7.6.1. Key country dynamics
7.6.2. Competitive scenario
7.6.3. Regulatory framework
7.6.4. Reimbursement scenario
7.6.5. Northeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Medtronic
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Integra LifeSciences
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. SOPHYSA
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Neuromedex
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Estimated Company Market Share Analysis, 2023
8.5. List of Other Key Market Players
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. EXTERNAL VENTRICULAR DRAIN MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidence of neurological disorders
3.2.1.2. Increasing healthcare expenditure
3.2.1.3. Developments of novel EVD technologies
3.2.2. Market Restraint Analysis
3.2.2.1. Infections and complications caused due to EVD insertion
3.2.3. Market Opportunities Analysis
3.2.3.1. Growing awareness regarding neurological illnesses
3.2.3.2. Increasing demand for minimally invasive procedures
3.3. U.S. External Ventricular Drain Market Analysis Tools
3.3.4. Industry Analysis - Porter’s Five Forces
3.3.4.1. Bargaining power of suppliers
3.3.4.2. Bargaining power of buyers
3.3.4.3. Threat of substitutes
3.3.4.4. Threat of new entrants
3.3.4.5. Competitive rivalry
3.3.5. PESTEL Analysis
3.3.5.1. Political & Legal Landscape
3.3.5.2. Economic and Social Landscape
3.3.5.3. Technological landscape
CHAPTER 4. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. External Ventricular Drain Market Movement Analysis
4.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
4.4. Traumatic Brain Injury
4.4.1. Traumatic Brain Injury Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Subarachnoid Hemorrhage
4.5.1. Subarachnoid Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Intracerebral Hemorrhage
4.6.1. Intracerebral Hemorrhage Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Other Non-traumatic Hydrocephalus Conditions
4.7.1. Other Non-traumatic Hydrocephalus Conditions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: PATIENT TYPE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. External Ventricular Drain Market Movement Analysis
5.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by Patient Type, 2018 to 2030 (USD Million)
5.4. Adult
5.4.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Pediatric
5.5.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: END-USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. External Ventricular Drain Market Movement Analysis
6.3. U.S. External Ventricular Drain Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. U.S. EXTERNAL VENTRICULAR DRAIN MARKET: COUNTRY ESTIMATES & TREND ANALYSIS BY APPLICATION, BY PATIENT TYPE, BY END-USE
7.1. Regional Dashboard
7.2. Market Size and Trend Analysis, 2018 to 2030
7.3. South
7.3.1. Key country dynamics
7.3.2. Competitive scenario
7.3.3. Regulatory framework
7.3.4. Reimbursement scenario
7.3.5. South Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. West
7.4.1. Key country dynamics
7.4.2. Competitive scenario
7.4.3. Regulatory framework
7.4.4. Reimbursement scenario
7.4.5. West Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Midwest
7.5.1. Key country dynamics
7.5.2. Competitive scenario
7.5.3. Regulatory framework
7.5.4. Reimbursement scenario
7.5.5. Midwest Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Northeast
7.6.1. Key country dynamics
7.6.2. Competitive scenario
7.6.3. Regulatory framework
7.6.4. Reimbursement scenario
7.6.5. Northeast Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Medtronic
8.2.1.1. Company Overview
8.2.1.2. Financial Performance
8.2.1.3. Product Benchmarking
8.2.1.4. Strategic Initiatives
8.2.2. Integra LifeSciences
8.2.2.1. Company Overview
8.2.2.2. Financial Performance
8.2.2.3. Product Benchmarking
8.2.2.4. Strategic Initiatives
8.2.3. SOPHYSA
8.2.3.1. Company Overview
8.2.3.2. Financial Performance
8.2.3.3. Product Benchmarking
8.2.3.4. Strategic Initiatives
8.2.4. Neuromedex
8.2.4.1. Company Overview
8.2.4.2. Financial Performance
8.2.4.3. Product Benchmarking
8.2.4.4. Strategic Initiatives
8.3. Heat Map Analysis/ Company Market Position Analysis
8.4. Estimated Company Market Share Analysis, 2023
8.5. List of Other Key Market Players
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. External ventricular drain market revenue estimates and forecast, by application, 2018 - 2030 (Million)
Table 4 U.S. External ventricular drain market revenue estimates and forecast, by patient type, 2018 - 2030 (Million)
Table 5 U.S. External ventricular drain market revenue estimates and forecast, by end use, 2018 - 2030 (Million)
Table 6 Key companies undergoing partnerships and collaborations
Table 7 Key companies undergoing product mergers and acquisitions
Table 8 Key companies undergoing product launch
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 U.S. External ventricular drain market revenue estimates and forecast, by application, 2018 - 2030 (Million)
Table 4 U.S. External ventricular drain market revenue estimates and forecast, by patient type, 2018 - 2030 (Million)
Table 5 U.S. External ventricular drain market revenue estimates and forecast, by end use, 2018 - 2030 (Million)
Table 6 Key companies undergoing partnerships and collaborations
Table 7 Key companies undergoing product mergers and acquisitions
Table 8 Key companies undergoing product launch
LIST OF FIGURES
Fig. 1 U.S. external ventricular drain market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Segment snapshot, 2023 & 2030 ( application and patient type)
Fig. 10 Segment snapshot, 2023 & 2030 (end use)
Fig. 11 Market concentration
Fig. 12 U.S. external ventricular drain market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 SWOT analysis, by factor (political, economic, social, technological, legal, and environmental)
Fig. 15 U.S. external ventricular drain market: By application Key takeaways
Fig. 16 U.S. external ventricular drain market, by application: Market Value, 2023 & 2030
Fig. 17 Traumatic brain injury market, 2018 - 2030 (USD Million)
Fig. 18 Subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
Fig. 19 Intracerebral hemorrhage market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 U.S. external ventricular drain market: By patient type Key takeaways
Fig. 22 U.S. external ventricular drain market, by patient type market value, 2023 & 2030
Fig. 23 Adult market, 2018 - 2030 (USD Million)
Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
Fig. 25 U.S. external ventricular drain market: By end use Key takeaways
Fig. 26 U.S. external ventricular drain market, by end use: Market value, 2023 & 2030
Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
Fig. 28 Others market, 2018 - 2030 (USD Million)
Fig. 29 Northeast market, 2018 - 2030 (USD Million)
Fig. 30 West market, 2018 - 2030 (USD Million)
Fig. 31 South market, 2018 - 2030 (USD Million)
Fig. 32 Midwest market, 2018 - 2030 (USD Million)
Fig. 33 Strategic framework ?
Fig. 1 U.S. external ventricular drain market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Segment snapshot, 2023 & 2030 ( application and patient type)
Fig. 10 Segment snapshot, 2023 & 2030 (end use)
Fig. 11 Market concentration
Fig. 12 U.S. external ventricular drain market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 SWOT analysis, by factor (political, economic, social, technological, legal, and environmental)
Fig. 15 U.S. external ventricular drain market: By application Key takeaways
Fig. 16 U.S. external ventricular drain market, by application: Market Value, 2023 & 2030
Fig. 17 Traumatic brain injury market, 2018 - 2030 (USD Million)
Fig. 18 Subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
Fig. 19 Intracerebral hemorrhage market, 2018 - 2030 (USD Million)
Fig. 20 Others market, 2018 - 2030 (USD Million)
Fig. 21 U.S. external ventricular drain market: By patient type Key takeaways
Fig. 22 U.S. external ventricular drain market, by patient type market value, 2023 & 2030
Fig. 23 Adult market, 2018 - 2030 (USD Million)
Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
Fig. 25 U.S. external ventricular drain market: By end use Key takeaways
Fig. 26 U.S. external ventricular drain market, by end use: Market value, 2023 & 2030
Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
Fig. 28 Others market, 2018 - 2030 (USD Million)
Fig. 29 Northeast market, 2018 - 2030 (USD Million)
Fig. 30 West market, 2018 - 2030 (USD Million)
Fig. 31 South market, 2018 - 2030 (USD Million)
Fig. 32 Midwest market, 2018 - 2030 (USD Million)
Fig. 33 Strategic framework ?
